IMI launches €224m R&D programme to tackle antibiotic resistance
This article was originally published in Scrip
Executive Summary
A new public-private R&D programme has been launched in Europe with the aim of developing new, more effective antimicrobials to tackle the increasing problem of bacterial resistance, on the premise that such products can only come from collaborative efforts and the pooling of knowledge from both sectors.